Live news related to NYXOAH stock (BE0974358906): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The stock of the Belgian medtech company specializing in sleep apnea treatment has shown a significant rebound this Tuesday, trading at 2.70 euros dur…
Belgian biotech Nyxoah reported mixed results for 2025 on Thursday evening. While revenue more than doubled to 10.0 million euros due to the commercia…
On Monday, March 16, 2026, NYXOAH shares continued to show negative signals: the stock hit a new all-time low during the session at €2.545 and fell ne…
Nyxoah SA announces its participation in the 36th Annual Oppenheimer Healthcare MedTech & Services Conference, to be held from March 16 to March 19, 2…
This Friday, Nyxoah recorded a new all-time low during the session, at 3.21 euros, before making a slight recovery. The stock of the Belgian medtech c…
Nyxoah has announced the signing of a memorandum of understanding with Sheikh Shakhbout Medical City (SSMC), a hospital in the United Arab Emirates sp…
The Belgian medical device specialist for the treatment of obstructive sleep apnea announces an investment in expanding its manufacturing capabilities…
Belgian medical technology company Nyxoah has released its unaudited preliminary results for the fiscal year 2025, marked by its first full quarter of…
Belgian medical technology company Nyxoah will participate in the 44th annual J.P. Morgan Healthcare Conference, to be held in San Francisco on Januar…
The Belgian medical device specialist for the treatment of sleep apnea has completed the first tranche of a convertible bond financing that could reac…
